findmyKOL
Clinical trialNCT05073315CompletedPhase 3Interventional

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

SponsorAmgenEnrollment425Plaque Psoriasis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Beacon Dermatology

    Calgary, Alberta, Canada

  • Dr. Chih-Ho Hong Medical Inc.

    Surrey, British Columbia, Canada

  • Cca Medical Research

    Ajax, Ontario, Canada

  • Simcoderm Medical & Surgical Dermatology Center

    Barrie, Ontario, Canada

  • Kingsway Clinical Research

    Etobicoke, Ontario, Canada

  • Guelph Dermatology Research

    Guelph, Ontario, Canada

  • Dermeffects

    London, Ontario, Canada

  • Dermedge Research Inc.

    Mississauga, Ontario, Canada

  • North Bay Dermatology Centre Inc.

    North Bay, Ontario, Canada

  • the Centre for Clinical Trials Inc.

    Oakville, Ontario, Canada

  • Skin Centre for Dermatology

    Peterborough, Ontario, Canada

  • the Centre for Dermatology

    Richmond Hill, Ontario, Canada

  • Toronto Research Centre - Dermatology

    Toronto, Ontario, Canada

  • Xlr8 Medical Research Inc.

    Windsor, Ontario, Canada

  • Dre Angélique Gagné-Henley Md Inc

    Saint-Jérôme, Quebec, Canada

Estonia
  • North Estonia Medical Centre

    Tallinn, Harju, Estonia

  • Clinical Research Center

    Tartu, Tartu, Estonia

  • Tartu University Hospital

    Tartu, Tartu, Estonia

Germany
  • Derma-Study-Center-Fn

    Friedrichshafen, Baden-Wurttemberg, Germany

  • Klinische Forschung Gruppe Nord (kfgn)

    Schwerin, Mecklenburg-Vorpommern, Germany

  • Hautzentrum Im Jahrhunderthaus

    Bochum, North Rhine-Westphalia, Germany

  • Klinische Forschung Dresden Gmbh

    Dresden, Saxony, Germany

  • Uksh Campus Kiel - Zeh (dermatologie)

    Kiel, Schleswig-Holstein, Germany

  • Rothhaar Studien Gmbh

    Berlin, Germany

  • Tfs Trial Form Support Gmbh

    Hamburg, Germany

Latvia
  • Health Centre 4 Ltd., Diagnostics Centre

    Riga, Rga, Latvia

  • J.Kisis Ltd

    Riga, Rga, Latvia

  • Riga 1st Hospital, Clinic of Dermatology and Std

    Riga, Rga, Latvia

  • Health and Aesthetics Ltd

    Riga, Latvia

  • Smite Aija Doctor Practice in Dermatology, Venereology

    Talsi, Latvia

Poland
  • High-Med Przychodnia Specjalistyczna

    Warsaw, Masovian Voivodeship, Poland

  • Royalderm Agnieszka Nawrocka

    Warsaw, Masovian Voivodeship, Poland

  • Clinicmed Daniluk, Nowak Sp. J.

    Bialystok, Podlaskie Voivodeship, Poland

  • Centrum Badan Klinicznych Pi-House Sp. Z O.O.

    Gdansk, Pomeranian Voivodeship, Poland

  • Care Clinic Sp. Z O.O.

    Katowice, Poland

  • Centrum Medyczne Angelius Provita

    Katowice, Poland

  • Centrum Nowoczesnych Terapii "dobry Lekarz" Sp. Z O.O.

    Krakow, Poland

  • Pratia Mcm Krakow

    Krakow, Poland

  • Centrum Terapii Wspolczesnej, J.M. Jasnorzewska S.K.A.

    Lodz, Poland

  • Nzoz All-Med Centrum Medyczne

    Lodz, Poland

48 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Oct 2021
Primary completion
19 Dec 2022
Completion
19 Dec 2022
Last update posted
9 Feb 2024
Registered enrollment
425
Registry id
NCT05073315

Cross-registrations

EU-CTR / CTIS (EudraCT)2021-000542-18

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.